Definium Therapeutics, Inc. (DFTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$166.31M | -60.0% |
| 2024 | -$103.92M | -10.7% |
| 2023 | -$93.87M | -41.5% |
| 2022 | -$66.33M | +29.3% |
| 2021 | -$93.85M | -184.1% |
| 2020 | -$33.03M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$166.31M | -60.0% |
| 2024 | -$103.92M | -10.7% |
| 2023 | -$93.87M | -41.5% |
| 2022 | -$66.33M | +29.3% |
| 2021 | -$93.85M | -184.1% |
| 2020 | -$33.03M | — |